Effectiveness of Engaging in Advance Care Planning Talks (ENACT) Group Visits in Primary Care for Older Adults With and Without Alzheimer's Disease

Sponsor
University of Colorado, Denver (Other)
Overall Status
Recruiting
CT.gov ID
NCT05421728
Collaborator
National Institute on Aging (NIA) (NIH)
110
8
4
57.6
13.8
0.2

Study Details

Study Description

Brief Summary

The main goal of the ENACT (ENgaging in Advance Care planning Talks) Group Visit intervention is to integrate a patient-centered advance care planning process into primary care, ultimately helping patients to receive medical care that is aligned with their values. The ENACT Group Visit intervention involves two group discussions about advance care planning with 8-10 patients who meet for 2-hour sessions, one month apart, facilitated by a geriatrician and a social worker. This study will compare the ENACT Group Visit intervention to mailed advance care planning materials.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: ENACT group visit
  • Behavioral: Mailed Resources
N/A

Detailed Description

This pilot feasibility randomized controlled study will determine the feasibility, acceptability and preliminary efficacy of the ENACT Group Visit intervention compared to a comparison arm.

The ENACT Group Visit intervention aims to engage patients in an interactive discussion of key ACP concepts and support patient-initiated ACP actions (i.e. choosing decision-maker(s), deciding on preferences during serious illness, discussing preferences with decision-makers and healthcare providers, and documenting advance directives). The group visits involve two 2-hour sessions, one month apart, facilitated by a geriatrician and a social worker. The ENACT Group Visit is based on an intervention manual that guides the structure, facilitator considerations, session format, and documentation and billing details. The discussions include sharing experiences related to ACP, considering values related to serious illness, choosing a surrogate decision-maker(s), flexibility in decision making, and having conversations with decision-makers and healthcare providers. The facilitators support an interactive discussion that promotes opportunities for patients to learn from others' experiences.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
110 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Randomized Controlled TrialRandomized Controlled Trial
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Effectiveness of Engaging in Advance Care Planning Talks (ENACT) Group Visits in Primary Care for Older Adults With and Without Alzheimer's Disease
Actual Study Start Date :
Jul 14, 2022
Anticipated Primary Completion Date :
May 1, 2027
Anticipated Study Completion Date :
May 1, 2027

Arms and Interventions

Arm Intervention/Treatment
Experimental: Participants: ENACT Group Visit

Participants will engage in two 2-hour group visits related to advance care planning, including printed advance care planning resources.

Behavioral: ENACT group visit
Participation in two 2 hour group visits about advance care planning.

Active Comparator: Participants: Mailed Resources

Participants will receive printed advance care planning resources by mail.

Behavioral: Mailed Resources
Participants will receive advance care planning resources in the mail with instructions to follow up with their primary care provider.

No Intervention: Clinic Stakeholders

Clinic stakeholders providing care for participants enrolled in the "Participants: Enact Group Visits" arm. Demographics, and adverse event data will not be collected for this arm.

No Intervention: Caregivers

Caregivers will be consented via postcard consent to facilitate patient participants' engagement in the trial and group visits. Outcome measure, demographics, and adverse event data will not be collected for this arm, however caregivers will assist participants in providing outcome measure data (responding to surveys, etc.)

Outcome Measures

Primary Outcome Measures

  1. Number of Participants with New Advanced Care Planning (ACP) documentation in their electronic health record at 6 Months [6 months]

    Number of Participants with New Advanced Care Planning (ACP) documentation in the electronic health record inclusive of advance directives (i.e., easy-to-read advance directive, medical durable power of attorney forms, living wills), and medical orders (POLST forms or CPR directives. If an advanced care planning document is completed and in patient's electronic health record, the participant will be counted as having a New ACP.

Secondary Outcome Measures

  1. Measure of readiness for ACP [Baseline, 6 months]

    Patient readiness for Advanced Care Planning (ACP) will be measured via the Advanced Care Planning (ACP) Engagement Survey. The 4-item ACP Engagement Survey assesses ACP readiness for signing papers for a decision maker; talking with a decision maker; talking with the doctor about future care; and signing papers about future care. Possible scores range from Possible scores for each item range from 1-5 and total scores range from 4-20, with higher indicating more planning readiness and a better outcome.

  2. Measure of decision self-efficacy [Baseline, 6 months]

    The 11-item Decision Self-Efficacy Scale measures self-confidence or belief in one's abilities in decision making. Possible scores range from 0 to 100, with higher scores indicating more decision self-efficacy and a better outcome.

  3. The Quality of Communication (QOC) [Baseline, 6 months]

    Quality of Communication (QOC) Questionnaire is a 13-item validated measure of the overall quality of end-of-life communication. Possible scores are averaged and range from 0 to 10, with higher scores indicating a better outcome.

  4. Composite of advanced care planning documentation [Baseline, 6 months]

    Clinician documentation of ACP (preferences for future medical care) in electronic health record will be measured using a standardized and double-adjudicated chart review audit process. The number of participants with clinician-documented ACP present in their electronic health records will be reported. Documentation of ACP that is added to the record as part of the ENACT group visits will be excluded.

Other Outcome Measures

  1. Percent of Recruitment (Reach) [From date of pre-screening until the date of participants' decision to enroll in study or not, up to 3 months]

    Percent of individuals who participate of eligible patients, by clinic-based screening

  2. Percent of Retention [6 Months]

    Percent of individuals who complete the intervention and the 6 month follow up

  3. Telephone Montreal Cognitive Assessment (T-MoCA) scores [Baseline, 6 months]

    The T-MoCA measures cognitive impairment in adults via a questionnaire conducted over the phone. Possible scores range from 0 to 22, with lower scores indicating a worse outcome.

  4. Patient Reported Outcome Measurement Information System Global Health Scores [Baseline, 6 months]

    The Patient Reported Outcomes Measurement Information System (PROMISĀ®) Global Health score measures patient reported measures of health. Scores are converted to a T score so that the average respondent score of 50 with a standard deviation of 10 points, with scores of higher than 50 indicating better than average outcomes, and scores of lower than 50 indicating worse than average outcomes.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Patient Participants:
Inclusion Criteria:
  • 70 or older

  • At least one clinic visit in past year

  • No advanced care planning (ACP) document in electronic health record based on a clinic-level, population-based report

  • Preferred language English for UCHealth clinics or preferred language English or Spanish for Denver Health clinic

Exclusion Criteria:
  • Inability to demonstrate informed consent

  • Does not have ready access to a telephone

  • Inability to travel to clinic

  • Moving out of area in 6 months

  • Inability to participate in group visits due to hearing impairment as determined by clinic and/or study staff

  • A household member (same address) is already enrolled

Caregivers

Inclusion Criteria:
  • Age 18 and older

  • Preferred language English for UCHealth clinics or preferred language English or Spanish for Denver Health clinic

  • Patient with potential cognitive impairment consented to participate in study

Exclusion Criteria:
  • Does not have ready access to a telephone

  • Inability to travel to clinic

  • Moving out of area in 6 months

  • Inability to participate in group visits due to hearing impairment as determined by clinic and/or study staff

Clinic Stakeholders

Inclusion Criteria:
  • Work as a multidisciplinary team member at a participating primary care clinic in the study

  • English speaking as a preferred language

  • Invited to participate in interviews or focus groups after the ENACT Group Visits intervention

Exclusion Criteria:
  • Inability to provide informed consent

Contacts and Locations

Locations

Site City State Country Postal Code
1 UCHealth Aurora Colorado United States 80045
2 UC Health Boulder Family Medicine Boulder Colorado United States 80303
3 Denver Health Westside Clinic Denver Colorado United States 80204
4 UC Health Lowry Internal Medicine Denver Colorado United States 80230
5 UC Health AF Williams Family Medicine Denver Colorado United States 80238
6 UC Health Lone Tree Seniors Lone Tree Colorado United States 80124
7 UC Health Lone Tree Primary Care Lonetree Colorado United States 80124
8 UC Health Westminster Primary Care Westminster Colorado United States 80021

Sponsors and Collaborators

  • University of Colorado, Denver
  • National Institute on Aging (NIA)

Investigators

  • Principal Investigator: Hillary Lum, MD, PhD, University of Colorado, Denver

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
University of Colorado, Denver
ClinicalTrials.gov Identifier:
NCT05421728
Other Study ID Numbers:
  • 20-1978
  • R01AG066804
First Posted:
Jun 16, 2022
Last Update Posted:
Jul 18, 2022
Last Verified:
Jul 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by University of Colorado, Denver
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 18, 2022